My Fund Comparison
Gabelli Healthcare & WellnessRX Trust Declares Year-End Distribution of $0.05 Per Share
Rye, NY, December 12, 2008 -- The Board of Trustees of The Gabelli Healthcare & WellnessRX Trust declared a year-end cash distribution of $0.05 per share payable on December 29, 2008 to common shareholders of record on December 22, 2008.
Based on the accounting records of the Fund as of December 10, 2008, the distribution would include approximately 23% from net investment income and 77% from net capital gains. After giving effect to the distribution, the aggregate of the accumulated undistributed net realized gains on the sale of securities and net unrealized depreciation of portfolio securities is $14,271,353, of which $14,827,518 represents net unrealized depreciation of portfolio securities. The estimated components of the distribution will be provided to shareholders of record in a notice accompanying the distribution and will be available on our website (www.gabelli.com). The final determination of the sources of the distribution will be made after year end and can vary from the estimate. All shareholders with taxable accounts will receive written notification regarding the components and tax treatment for the distribution in early 2009 via Form 1099-DIV.
The Gabelli Healthcare & WellnessRx Trust is a non-diversified, closed-end management investment company with $51 million in total assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (GBL) , which is a publicly traded NYSE listed company.
View more information on Gabelli Funds or other Closed-End Funds
Aberdeen Closed-End TV
National Association of
Publicly Traded Partnerships
Seeking Alpha CEF Articles
Powered by a SySys®
data & content management system.
©Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.